SVNS.
43 announcements.
43 announcements.
| Time | Date | Ticker | Company | Announcement |
|---|---|---|---|---|
| 07:00 | 28-08-2025 | SVNS | SVNS | Solvonis secures exclusive CNS collaboration |
| 15:03 | 13-08-2025 | SVNS | SVNS | Media Coverage: Small Cap Idea profile |
| 07:00 | 12-08-2025 | SVNS | SVNS | SVN-SDN-14 PTSD - Positive pre-clinical results |
| 07:00 | 14-07-2025 | SVNS | SVNS | Solvonis Chair to speak at Lucid Capital Markets |
| 07:00 | 11-07-2025 | SVNS | SVNS | £1m subscription to accelerate AI drug discovery |
| 07:00 | 08-07-2025 | SVNS | SVNS | Holding(s) in Company |
| 14:38 | 27-06-2025 | SVNS | SVNS | AGM Statement |
| 08:54 | 27-06-2025 | SVNS | SVNS | Holding(s) in Company |
| 10:21 | 26-06-2025 | SVNS | SVNS | Initiation of Research Coverage |
| 07:00 | 23-06-2025 | SVNS | SVNS | Allowance of U.S. patent covering AI-supported CNS |
| 07:30 | 11-06-2025 | SVNS | SVNS | Initiation of AI supported CNS drug discovery |
| 07:00 | 05-06-2025 | SVNS | SVNS | Synthesis of development candidate for SVN-SDN-014 |
| 16:30 | 03-06-2025 | SVNS | SVNS | Notice of Annual General Meeting |
| 07:00 | 03-06-2025 | SVNS | SVNS | Appointment of Prof. David Nutt as CSO |
| 11:58 | 02-06-2025 | SVNS | SVNS | Holding(s) in Company |
| 17:00 | 30-05-2025 | SVNS | SVNS | Total Voting Rights |
| 15:11 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
| 12:02 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
| 10:30 | 29-05-2025 | SVNS | SVNS | Holding(s) in Company |
| 07:00 | 29-05-2025 | SVNS | SVNS | Presentation at Mello2025 |
| 07:30 | 28-05-2025 | SVNS | SVNS | Holding(s) in Company |
| 07:00 | 28-05-2025 | SVNS | SVNS | Completion of the acquisition of Awakn |
| 15:24 | 21-05-2025 | SVNS | SVNS | Publication of a Prospectus |
| 07:31 | 16-05-2025 | SVNS | SVNS | Result of placing |
| 16:53 | 15-05-2025 | SVNS | SVNS | Proposed equity fundraising via ABB |
| 11:30 | 28-04-2025 | SVNS | SVNS | Result of General Meeting |
| 07:00 | 23-04-2025 | SVNS | SVNS | Proposed acquisition of Awakn approved |
| 07:00 | 16-04-2025 | SVNS | SVNS | Final Results for the year ended 31 December 2024 |
| 14:00 | 10-04-2025 | SVNS | SVNS | Posting of Circular and Notice of General Meeting |
| 07:00 | 07-04-2025 | SVNS | SVNS | Holding(s) in Company |
| 07:00 | 04-04-2025 | SVNS | SVNS | Engagement of PharmaVentures |
| 07:00 | 26-03-2025 | SVNS | SVNS | Positive progress on European Patent Application |
| 07:00 | 18-03-2025 | SVNS | SVNS | Update on AWKN-SDN-14 programme |
| 09:00 | 11-03-2025 | SVNS | SVNS | Holding(s) in Company |
| 07:00 | 11-03-2025 | SVNS | SVNS | Appointment of Non-Executive Director |
| 07:00 | 25-02-2025 | SVNS | SVNS | Presentation at PharmaSynergyRx Event |
| 07:00 | 24-02-2025 | SVNS | SVNS | Entry into an Arrangement Agreement with Awakn |
| 12:00 | 30-01-2025 | SVNS | SVNS | Proactive Investors interview with Chairman |
| 07:00 | 27-01-2025 | SVNS | SVNS | Update on Awakn Life Sciences’ R&D Progress |
| 07:00 | 24-01-2025 | SVNS | SVNS | Investor Presentation |
| 14:29 | 21-01-2025 | SVNS | SVNS | Proactive Investors interview with CEO |
| 07:00 | 21-01-2025 | SVNS | SVNS | Update on FDA Pre-IND Meeting for Awakn |
| 07:00 | 15-01-2025 | SVNS | SVNS | Interview with CEO |